CorePharma SARS-COV-2 AND INFLUENZA A+B Antigen Combo Rapid Test

CorePharma is a medical technology brand specializing in rapid diagnostic solutions. The SARS-COV-2 and Influenza A+B Antigen Combo Rapid Test is a diagnostic tool designed for self-testing, allowing users to detect viral antigens for both COVID-19 and common flu strains simultaneously. These kits are typically manufactured in high-capacity facilities in China, which serves as a global hub for rapid antigen test production.

The brand is owned by Core Technology Co., Ltd., a biotechnology firm headquartered in Beijing. The company focuses on the research, development, and distribution of In Vitro Diagnostic (IVD) products. While they distribute globally, their manufacturing and corporate operations remain centered in China, providing medical supplies to both professional healthcare providers and the consumer retail market.